6 research outputs found

    Mineral Resources of the Marble Canyon Wilderness Study Area, White Pine County, Nevada, and Millard County, Utah

    Get PDF
    The 19,150-acre Marble Canyon Wilderness Study Area (NV-040-086) was evaluated for mineral resources (known) and mineral resource potential (undiscovered), and field work was conducted in 1987. The acreage includes 6,435 acres that is now designated as part of the Mount Moriah Wilderness under the Nevada Wilderness Protection Act of 1989 (S. 974), most but not all of which is included in 8,300 acres fro which the U.S. Bureau of Land Management requested a mineral survey. In this report, the wilderness study area, or simply the study area refers to the entire 19,150-acre tract. The area in underlain by quartzite shale and carbonate rocks. The norther Snake Range decollement is a detachment surface within the study area that separates rocks of similar age but different metamorphic grade. Large inferred subeconomic limestone and marble resources i the study area have no special or unique properties. The mineral resource potential for limestone and marble is high in two canyons and is moderate in the rest of the wilderness study area. Parts of the study area above and along the northern Snake Range decollement have low potential for undiscovered deposits of gold, silver, copper, lead, zinc, tungsten, molybdenum, beryllium, and flourite. A zone around barite-bearing rock penetrated by adits inside the southeast boundary of the study area has moderate potential for barite, and the surrounding area has low potential for barite; both areas also have low potential for silver, copper, lead, zinc, and tungsten. The entire study area has moderate potential for oil and gas and low potential for geothermal energy resources

    A Haemophilus sp. dominates the microbiota of sputum from UK adults with non-severe community acquired pneumonia and chronic lung disease

    Get PDF
    Abstract The demographics and comorbidities of patients with community acquired pneumonia (CAP) vary enormously but stratified treatment is difficult because aetiological studies have failed to comprehensively identify the pathogens. Our aim was to describe the bacterial microbiota of CAP and relate these to clinical characteristics in order to inform future trials of treatment stratified by co-morbidity. CAP patients were prospectively recruited at two UK hospitals. We used 16S rRNA gene sequencing to identify the dominant bacteria in sputum and compositional data analysis to determine associations with patient characteristics. We analysed sputum samples from 77 patients and found a Streptococcus sp. and a Haemophilus sp. were the most relatively abundant pathogens. The Haemophilus sp. was more likely to be dominant in patients with pre-existing lung disease, and its relative abundance was associated with qPCR levels of Haemophilus influenzae. The most abundant Streptococcus sp. was associated with qPCR levels of Streptococcus pneumoniae but dominance could not be predicted from clinical characteristics. These data suggest chronic lung disease influences the microbiota of sputum in patients with CAP. This finding could inform a trial of stratifying empirical CAP antibiotics to target Haemophilus spp. in addition to Streptococcus spp. in those with chronic lung disease
    corecore